PRPO Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 18:59):

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services...

Stats
Dagens volum	3 345.00
Gjennomsnittsvolum	5 280.00
Markedsverdi	7.93M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-0.930 ) 2024-05-15
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.280
ATR14	$0.112 (1.94%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	Laporte Kathleen	Buy	9 693	Common Stock
2024-04-15	Sandberg Richard A	Buy	5 913	Common Stock
2024-04-15	Cossman Jeffrey	Buy	8 143	Common Stock
2024-04-15	Cohen David Seth	Buy	3 575	Common Stock
2024-04-15	Andrews Ronald Asbury	Buy	3 153	Common Stock

INSIDER POWER
99.41
Last 96 transactions
Buy: 2 731 117 \| Sell: 221 280

Precipio Inc Korrelasjon

10 Mest positive korrelasjoner
SLGC	0.874
VUZI	0.835
SIFY	0.833
MOGO	0.829
TCON	0.821
SBGI	0.811
ISPC	0.807
STAA	0.802
PCT	0.801

10 Mest negative korrelasjoner
BNIXU	-0.894

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Precipio Inc Økonomi

Annual	2023
Omsetning:	$15.20M
Bruttogevinst:	$4.50M (29.62 %)
EPS:	$-4.51

FY	2023
Omsetning:	$15.20M
Bruttogevinst:	$4.50M (29.62 %)
EPS:	$-4.51

FY	2022
Omsetning:	$9.41M
Bruttogevinst:	$2.51M (26.67 %)
EPS:	$-10.73

FY	2021
Omsetning:	$8.85M
Bruttogevinst:	$2.39M (27.03 %)
EPS:	$-0.400

Financial Reports:

No articles found.

Precipio Inc

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.